171 related articles for article (PubMed ID: 54945)
1. Urinary fibrin/fibrinogen derivatives.
Hedner U
Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
[No Abstract] [Full Text] [Related]
2. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
Panchenko VM; Gilunova NI; Kozhomkulova BZh
Lab Delo; 1977; (8):451-4. PubMed ID: 72846
[No Abstract] [Full Text] [Related]
3. [The fibrinolytic therapy in renal disease (author's transl)].
Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
[No Abstract] [Full Text] [Related]
4. [Fibrin degradation products in the urine in renal diseases].
Iversen BM; Ofstad J; Thunold S; Willassen Y
Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
[No Abstract] [Full Text] [Related]
5. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
6. Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis.
Hedner U; Ekberg M; Nilsson IM
Acta Med Scand; 1974; 195(1-2):81-5. PubMed ID: 4817097
[No Abstract] [Full Text] [Related]
7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].
Drannik GN
Urol Nefrol (Mosk); 1979; (2):62-9. PubMed ID: 375530
[No Abstract] [Full Text] [Related]
9. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Ekberg M; Pandolfi M
Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
[TBL] [Abstract][Full Text] [Related]
10. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
[No Abstract] [Full Text] [Related]
11. Urinary fibrin split products in lupus nephritis.
Zizic TM; Cwazka WF; Young NS; Stevens MB
J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
[TBL] [Abstract][Full Text] [Related]
12. [The investigation on early diagnosis of the bladder tumor. II: A study on urinary cytology, urinary fibrin/fibrinogen degradation products, tissue fibrin deposition and tissue plasminogen activator activity in patients with bladder tumors (author's transl)].
Tanahashi T
Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1047-54. PubMed ID: 7193258
[No Abstract] [Full Text] [Related]
13. [Origin of urinary FDP in children with renal diseases].
Yoshioka K; Iseki T; Ikeda H; Akano N; Uraoka Y; Miyata H; Maki S
Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):285-93. PubMed ID: 7120693
[No Abstract] [Full Text] [Related]
14. A sensitive and specific assay for plasminogen activators.
Smith DS; Harmon J; Owen WG
Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Lipinski B; Gurewich V; Hyde E
Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
[No Abstract] [Full Text] [Related]
17. [Enzymatic determination of plasminogen activators].
Fischer BE
Z Med Lab Diagn; 1988; 29(6):327-32. PubMed ID: 2973186
[No Abstract] [Full Text] [Related]
18. A kinetic evaluation of hemostasis in renal disease.
George CR; Slichter SJ; Quadracci LJ; Striker GE; Harker LA
N Engl J Med; 1974 Nov; 291(21):1111-5. PubMed ID: 4608640
[No Abstract] [Full Text] [Related]
19. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
Bachmann HJ; Tacke E; Haupt H
Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
[No Abstract] [Full Text] [Related]
20. Urinary fibrinogen and fibrin fragments in children with renal disease.
Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
